drug developer

The company is working on a bespoke pharmacovigilance product that will leverage its biomedical content, and has added an NGS module to Pathway Studio. 

The collaboration will focus on identifying new signaling pathways and targets involved in coronary artery disease.

The Associated Press reports that the US Food and Drug Administration approved 45 new drugs last year.

The partners will focus on developing gene editing-based treatments for cystic fibrosis and sickle cell disease, among other diseases.

Therapies aimed at drug targets that have been linked genetically to disease fare better through the drug development pipeline, researchers from GSK and elsewhere found.

The partners will provide drug discovery services, expertise, and infrastructure in a new AMRI center located in the Buffalo Medical Innovation and Commercialization Hub.

The partners will develop novel drug candidates based on an activated kinase target for an unnamed rare genetic disease.

The New Zealand firm, which is "evaluating all options," has also been unable to secure the more than $1 million it is owed for selling its stake in a biofuels shop, or to find funding from a government technology-investment group.

The agreement, which eliminates all of MDRNA's non-RNAi expenses, "represents the final step in our plan to create a company solely focused in the research and development of RNAi-based therapeutics," Michael French, president and CEO of MDRNA, said in a statement.

Both companies failed to meet the Nasdaq Global Market's minimum shareholder listing requirement. But while MDRNA aims to keep its shares remain on the exchange's top tier, Arrowhead instead requested its stock be moved to the Capital Market, where the listing requirements are less stringent.

Pages

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.

New Scientist reports that 20 percent of human and yeast proteins are uncharacterized.

The University of Zurich's Ruedi Aebersold and his colleagues analyzed a dozen HeLa cell lines to find differences in gene expression, protein levels, and more.

In Nature this week: protein-coding variants associated with body-fat distribution, and more.